TGFB1 and neoplasm: Accordingly, experimental targeting of EZH2 triggers the cell death and inhibits the cellular invasion [130] as well as inhibits the expression of target tumor suppressor gene, such as transforming growth factor-beta1 (TGF-β1) [131].